Teladoc Health (TDOC) Cost of Revenue (2014 - 2026)

Teladoc Health has disclosed Cost of Revenue across 13 years of filings, most recently posting $51.3 million for Q1 2026.

• Cost of Revenue for Q1 2026 came in at $51.3 million, down 73.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $626.0 million (down 46.2% YoY), and the FY2025 annual result was $771.6 million, up 2.71% from the prior year.
• Cost of Revenue came in at $51.3 million for Q1 2026 at Teladoc Health, down from $197.0 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $599.7 million in Q4 2023 to a low of -$327.9 million in Q4 2022.
• The 5-year median for Cost of Revenue is $179.7 million (2024), against an average of $151.5 million.
• Across the five-year window, Cost of Revenue tumbled 171.45% in 2022 and jumped 282.87% in 2023, its largest moves.
• Teladoc Health's Cost of Revenue stood at -$327.9 million in 2022, then surged by 282.87% to $599.7 million in 2023, then fell by 0.12% to $599.0 million in 2024, then tumbled by 67.1% to $197.0 million in 2025, then plunged by 73.98% to $51.3 million in 2026.
• The last three Cost of Revenue figures came in at $51.3 million (Q1 2026), $197.0 million (Q4 2025), and $187.2 million (Q3 2025), per Business Quant data.